Fjarde Ap Fonden Catalent, Inc. Transaction History

Fjarde Ap Fonden

$9.04 Billion
Q1 2024

A detailed history of Fjarde Ap Fonden transactions in Catalent, Inc. stock. As of the latest transaction made, Fjarde Ap Fonden holds 33,500 shares of CTLT stock, worth $1.88 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

33,500

Previous 34,800 3.74%

Holding current value

$1.88 Million

Previous $1.56 Million 20.91%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$42.56 - $59.82 $55,328 - $77,766	-1,300 Reduced 3.74%	33,500 $1.89 Million
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $35,398 - $51,227	1,100 Added 3.26%	34,800 $1.56 Million
Q3 2023 Oct 23, 2023	BUY	$44.2 - $50.2 $344,760 - $391,560	7,800 Added 30.12%	33,700 $1.53 Million
Q2 2023 Aug 02, 2023	BUY	$31.86 - $67.26 $277,182 - $585,162	8,700 Added 50.58%	25,900 $1.12 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $781,568 - $1.28 Million	17,200 New	17,200 $1.13 Million

Q2 2022 Aug 11, 2022	SELL	$87.2 - $114.05 $1.12 Million - $1.46 Million	-12,800 Reduced 33.0%	25,989 $2.79 Million
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $1.07 Million - $1.42 Million	-11,390 Reduced 22.7%	38,789 $4.3 Million
Q4 2021 Feb 15, 2022	BUY	$119.57 - $139.07 $117,059 - $136,149	979 Added 1.99%	50,179 $6.42 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $480,348 - $626,340	-4,400 Reduced 8.21%	49,200 $6.55 Million
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $162,416 - $200,432	1,600 Added 3.08%	53,600 $5.65 Million
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $2.18 Million - $2.68 Million	25,400 Added 95.49%	52,000 $5.41 Million
Q3 2020 Nov 13, 2020	SELL	$72.74 - $92.5 $1.87 Million - $2.38 Million	-25,700 Reduced 49.14%	26,600 $2.28 Million
Q2 2020 Aug 13, 2020	BUY	$48.02 - $79.04 $2.51 Million - $4.13 Million	52,300 New	52,300 $3.83 Million

Others Institutions Holding CTLT

# of Institutions

484

Shares Held

172M

Call Options Held

865K

Put Options Held

687K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.1B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account